Skip to main content
Premium Trial:

Request an Annual Quote

The R&D Crystal Ball

A funding forecast put together by Battelle and R&D Magazine foresees global R&D spending in the life sciences increasing from $181.6 billion in 2012 to $189.3 billion in 2013, and an increase from $81.5 billion to 82.7 billion for the US.

"The estimates and forecast show that US industry should turn the corner and begin increasing their R&D investment in 2013," the report says. "The global industry, while affected by a slowdown from 2009 to 2012 is on a stronger R&D growth trajectory into 2013."

Battelle and R&D Magazine also surveyed about 275 members of the R&D community, MedCity News adds, and the respondents were optimistic about 2013, with more than half of the respondents saying they expected their R&D budgets to increase this year as compared to last.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.